The Fort Worth Press - Medical Care Technologies Inc. (OTCID:MDCE) Reports Strong Internal Technical Evaluation Results for Wound Monitoring Application

USD -
AED 3.672503
AFN 65.000331
ALL 81.855804
AMD 361.666242
ANG 1.790365
AOA 918.000216
ARS 1516.747499
AUD 1.433949
AWG 1.8
AZN 1.699029
BAM 1.75007
BBD 2.014862
BDT 123.150572
BGN 1.683441
BHD 0.377597
BIF 2993.213105
BMD 1
BND 1.281167
BOB 11.849764
BRL 4.9915
BSD 1.000362
BTN 95.757408
BWP 13.762835
BYN 3.017158
BYR 19600
BZD 2.011999
CAD 1.426125
CDF 2310.000336
CHF 0.832725
CLF 0.024821
CLP 976.869896
CNY 6.69215
CNH 6.693709
COP 3204.51
CRC 455.621222
CUC 1
CUP 24.010451
CVE 98.666285
CZK 21.814702
DJF 178.147832
DKK 6.68528
DOP 60.747601
DZD 134.613005
EGP 52.688702
ERN 15
ETB 163.410241
EUR 0.89425
FJD 2.24725
FKP 0.755381
GBP 0.755545
GEL 2.590134
GGP 0.755381
GHS 11.764759
GIP 0.755381
GMD 73.50184
GNF 8801.199025
GTQ 7.647672
GYD 209.197346
HKD 7.84744
HNL 26.853679
HRK 6.740495
HTG 131.006868
HUF 326.552499
IDR 17949
ILS 3.070005
IMP 0.755381
INR 95.64895
IQD 1516.587254
IRR 1779469.999976
ISK 122.009931
JEP 0.755381
JMD 159.428395
JOD 0.708982
JPY 158.583999
KES 129.709921
KGS 87.450114
KHR 4061.472384
KMF 440.000315
KPW 900.000318
KRW 1333.39704
KWD 0.31133
KYD 0.83368
KZT 450.673097
LAK 22494.642322
LBP 89587.097063
LKR 331.142539
LRD 170.576208
LSL 16.549941
LTL 2.95274
LVL 0.60489
LYD 6.428319
MAD 9.679166
MDL 17.917366
MGA 4512.529585
MKD 55.100461
MMK 2100.025299
MNT 3596.153429
MOP 8.086399
MRU 40.212066
MUR 47.529996
MVR 15.450203
MWK 1734.769206
MXN 18.34505
MYR 4.092896
MZN 63.910165
NAD 16.549941
NGN 1331.060384
NIO 36.811188
NOK 9.56565
NPR 153.214773
NZD 1.78579
OMR 0.3845
PAB 1.00038
PEN 3.44445
PGK 4.471368
PHP 62.763992
PKR 276.99451
PLN 3.922275
PYG 5690.893229
QAR 3.657001
RON 4.7737
RSD 105.018034
RUB 83.950379
RWF 1475.068787
SAR 3.75677
SBD 8.078071
SCR 13.839567
SDG 601.495433
SEK 10.013895
SGD 1.280211
SHP 0.755572
SLE 24.670214
SLL 20969.491881
SOS 571.773706
SRD 37.692503
STD 20697.981008
STN 21.922074
SVC 8.753932
SYP 13002.000254
SZL 16.544455
THB 33.615993
TJS 9.218882
TMT 3.51
TND 2.992694
TOP 2.40776
TRY 49.336835
TTD 6.803001
TWD 31.938969
TZS 2644.993021
UAH 45.034652
UGX 4132.087205
UYU 40.23891
UZS 11905.241259
VES 875.701599
VND 25937
VUV 119.754657
WST 2.785507
XAF 586.589563
XAG 0.016497
XAU 0.00023988006
XCD 2.70255
XCG 1.802979
XDR 0.707052
XOF 586.589563
XPF 106.711286
YER 236.198559
ZAR 16.54105
ZMK 9001.201015
ZMW 19.858175
ZWL 321.999592
SSP 5757.531856
MXV 2.071829
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Medical Care Technologies Inc. (OTCID:MDCE) Reports Strong Internal Technical Evaluation Results for Wound Monitoring Application
Medical Care Technologies Inc. (OTCID:MDCE) Reports Strong Internal Technical Evaluation Results for Wound Monitoring Application

Medical Care Technologies Inc. (OTCID:MDCE) Reports Strong Internal Technical Evaluation Results for Wound Monitoring Application

Image-Quality Pass Rate of 84%, Boundary Stability of 87% and Sequential Alignment Completion of 91% on Controlled Captures as Models Continue Training

Text size:

MESA, AZ / ACCESS Newswire / October 12, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today published updated internal technical evaluation results for its MDCE Wound Monitoring application on the Company's corporate website.

The full summary is available at https://www.medicalcaretechnologies.com.

This release fulfills the Company's October 7 announcement that a public technical summary would be posted on October 12. The results cover three model layers under active training. They are internal evaluation metrics from the Company's multi-phase testing protocol on controlled sequential smartphone captures. They are not clinical study results, not a measure of clinical efficacy, and not a claim of diagnostic or therapeutic performance.

Image-quality scoring
In the latest internal pass, successive captures were scored for focus, distance consistency, lighting and framing before any comparison was attempted. 84% of controlled sequential captures met the Company's internal usability threshold and advanced to comparison. Frames below threshold - typically from motion blur, extreme distance or inconsistent lighting - were held out. The operational result is that the workflow can reject unusable input rather than force a comparison on a poor frame.

Wound-boundary segmentation
On frames that passed the quality filter, the model was evaluated for edge definition and area organization of the visible wound region across successive captures of the same site. Internal scoring showed 87% boundary stability on usable sequences, with reduced drift relative to the prior internal cycle when lighting and distance remained within the usable range. Segmentation remains sensitive to partial occlusion and low-contrast edges, which are active training targets.

Longitudinal comparison
Where two or more usable frames of the same site were available, the platform attempted alignment for side-by-side visual review. The internal alignment completion rate on multi-frame usable sequences was 91%. Sequential smartphone images that clear the quality filter can be organized for change-over-time visual review. This is a workflow finding, not a clinical finding.

The models remain in continuous training. Subsequent cycles are intended to increase the share of everyday user-captured sequences that clear the quality gate on the first attempt and to tighten segmentation on low-contrast edges.

The commercial context is large. The Company has previously cited the chronic wound care market as exceeding $20 billion annually and projected to surpass $30 billion by 2030, driven by diabetes, aging populations and the cost of late intervention. MDCE is building a monitoring workflow for that market. It is not claiming regulatory clearance, a launched device or measured clinical outcomes.

"These are the internal numbers we said we would publish," said Marshall Perkins, CEO of Medical Care Technologies. "Eighty-four percent of controlled captures cleared the quality gate. Boundary stability on usable sequences was 87 percent. Alignment completed on 91 percent of multi-frame usable sequences. The models are still training, and the next cycle is already aimed at everyday capture conditions. Investors can see the technical progress on the corporate site."

The wound-monitoring application remains in development. It has not received regulatory clearance and is not intended to diagnose, treat, cure, or prevent any disease or medical condition. It is not a substitute for professional medical advice, wound care, or evaluation by a qualified healthcare provider. Any concerning change in a wound should be reviewed by a licensed clinician. The metrics reported above are internal technical evaluation results, not clinical efficacy results.

Medical Care Technologies continues Melanoma Scan Beta volunteer-image review, StrainScan Pro enterprise demonstrations, Snapshot Recipes consumer activity, and subsidiary operations at Infinite Auctions and Real Game Used.

About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. Visit: https://www.medicalcaretechnologies.com

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding model training and future evaluation cycles. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.

Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: [email protected]
Website: https://www.medicalcaretechnologies.com

SOURCE: Medical Care Technologies Inc.



View the original press release on ACCESS Newswire

L.Davila--TFWP